1. Home
  2. DSGN vs REI Comparison

DSGN vs REI Comparison

Compare DSGN & REI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSGN
  • REI
  • Stock Information
  • Founded
  • DSGN 2017
  • REI 2004
  • Country
  • DSGN United States
  • REI United States
  • Employees
  • DSGN N/A
  • REI N/A
  • Industry
  • DSGN Biotechnology: Pharmaceutical Preparations
  • REI Oil & Gas Production
  • Sector
  • DSGN Health Care
  • REI Energy
  • Exchange
  • DSGN Nasdaq
  • REI Nasdaq
  • Market Cap
  • DSGN 208.9M
  • REI 208.6M
  • IPO Year
  • DSGN 2021
  • REI N/A
  • Fundamental
  • Price
  • DSGN $5.85
  • REI $1.05
  • Analyst Decision
  • DSGN
  • REI
  • Analyst Count
  • DSGN 0
  • REI 0
  • Target Price
  • DSGN N/A
  • REI N/A
  • AVG Volume (30 Days)
  • DSGN 167.2K
  • REI 2.6M
  • Earning Date
  • DSGN 11-06-2025
  • REI 11-05-2025
  • Dividend Yield
  • DSGN N/A
  • REI N/A
  • EPS Growth
  • DSGN N/A
  • REI N/A
  • EPS
  • DSGN N/A
  • REI 0.35
  • Revenue
  • DSGN N/A
  • REI $318,900,835.00
  • Revenue This Year
  • DSGN N/A
  • REI N/A
  • Revenue Next Year
  • DSGN N/A
  • REI $9.58
  • P/E Ratio
  • DSGN N/A
  • REI $3.05
  • Revenue Growth
  • DSGN N/A
  • REI N/A
  • 52 Week Low
  • DSGN $2.60
  • REI $0.72
  • 52 Week High
  • DSGN $7.77
  • REI $1.81
  • Technical
  • Relative Strength Index (RSI)
  • DSGN 55.18
  • REI 59.49
  • Support Level
  • DSGN $5.65
  • REI $0.97
  • Resistance Level
  • DSGN $6.65
  • REI $1.08
  • Average True Range (ATR)
  • DSGN 0.49
  • REI 0.06
  • MACD
  • DSGN -0.05
  • REI -0.01
  • Stochastic Oscillator
  • DSGN 50.40
  • REI 47.37

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

About REI Ring Energy Inc.

Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.

Share on Social Networks: